BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Thermo Fisher Scientific Expands PPD Laboratory Services Network With New Bioanalytical Facility In Sweden

The state-of-the-art facility enhances support for complex modalities across all phases of drug development Key facts Thermo Fisher opens new bioa...

May 18, 2026 | News

NinaMED Pty Ltd Launches With US$13.75 Million Financing To Advance Non Invasive OAB Therapy

US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd, a new Australian medtech com...

May 18, 2026 | News

FDA Approves First All Oral INQOVI Plus Venetoclax Regimen For Newly Diagnosed AML Patients Ineligible For Intensive Chemotherapy

Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has approved INQOVI (decitabine and ced...

May 15, 2026 | News

Suzhou Ribo Life Science And Insilico Medicine Forge Strategic Alliance To Accelerate AI Powered siRNA Drug Development

Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Me...

May 14, 2026 | News

Isomorphic Labs Raises $2.1 Billion To Scale AI Driven Drug Discovery Platform

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline...

May 14, 2026 | News

GenScript Biotech Launches TurboCHO Protein Expression Kit To Accelerate Antibody Discovery Workflows

New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the laun...

May 14, 2026 | News

Benchling Launches Antibody R&D Platform To Accelerate Biologics Discovery And Development

Benchling announced Benchling Biologics, an end-to-end platform for antibody R&D, today at the PEGS Boston Summit. Scientists can configure a...

May 13, 2026 | News

Cellenkos Advances CK0802 Into Phase 1b 2a Trial Following FDA Clearance For Steroid Refractory GVHD

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with s...

May 06, 2026 | News

Quantum Breakthrough Enables Largest Ever Protein Simulations Advancing Drug Discovery Potential

Scientists at Cleveland Clinic, RIKEN, and IBM (NYSE: IBM) have used IBM quantum computers and two of the world's most powerful supercomputers to simu...

May 06, 2026 | News

UltraGreen.ai Secures Singapore Approval For Verdye Strengthening Southeast Asia Surgical Innovation Strategy

Approval in a strategic healthcare hub strengthens regional growth strategy and supports clinical adoption of fluorescence-guided surgery Ultr...

May 06, 2026 | News

EnGeneIC Doses First Patient In Trial Targeting Recurrent Glioblastoma

EnGeneIC announced that the first patient has been dosed in its clinical trial evaluating EnGeneIC’s investigational EGFR-targeted EDV™ (EnGene...

May 05, 2026 | News

Restore Vision Reports Encouraging Phase I II Data For RV 001 Gene Therapy In Retinitis Pigmentosa

Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis Pigmentosa are presented at key Ma...

May 04, 2026 | News

Genexine Advances First In Class SOX2 Targeting BioPROTAC GX BP1 With Strong Preclinical Anti Tumour Data

Genexine, Inc. (KOSDAQ: 095700), a clinical-stage biotechnology company, announced new preclinical data for its SOX2-targeting bioPROTAC candidate, G...

May 04, 2026 | News

Insilico Medicine Secures IND Clearance For Rentosertib Inhalation Solution To Advance Targeted IPF Therapy

Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and dose-dependent efficacy impr...

April 30, 2026 | News

Stay Connected